Southwest Autism Research and Resource Center

Phoenix, Arizona 85006

3 studies enrolling now · 24 studies all time

What they study most

Anxiety, Attention Deficit/Hyperactivity Disorder, Autism, Autism Spectrum Disorder, Autism Spectrum Disorder (ASD), Autistic Disorder, Behavioral Symptoms, Bipolar Disorder, Child Development Disorders, Pervasive, Depressive Disorder, Major, Fragile X Syndrome, Gastrointestinal Diseases

Studies at this site

• Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder — Recruiting now
• Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients — Recruiting now
• Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults — Recruiting now
• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD) — Completed
• ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD) — Running, not enrolling
• Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS — Running, not enrolling
• A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. — Completed
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD) — Completed
• In-Person Mindfulness-based Intervention for Adolescents With Autism Spectrum Disorder and Their Caregivers — Completed
• Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder — Stopped early
• Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD) — Completed
• A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy — Stopped early
• A Study to Investigate the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Participants With Autism Spectrum Disorder — Completed
• A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD) — Completed
• A 12-Week Crossover Study to Assess the Efficacy, Safety and Tolerability of L1-79 in Subjects Aged 12-21 Years With Autism Spectrum Disorder — Completed
• Mindfulness-Based Intervention for Teens With Autism Spectrum Disorder and Their Caregivers — Completed
• Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148 — Completed
• A Multi-site Comparison of Social Visual Engagement to Clinical Diagnosis for Autism Spectrum Disorder — Completed
• Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX) — Completed
• A Study to Evaluate Scales for Repetitive and Restricted Behaviors in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD) — Completed
• A Trial of CM-AT in Children With Autism- Open Label Extension Study — Completed
• A Trial of CM-AT in Children With Autism — Completed
• Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder — Completed
• Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism — Status unconfirmed